| Detailed information |
|---|
| CancerLivER ID | 2264 |
| Biomarker | TNF |
| Biomarker Name/Symbol (given in Publication) | TNF |
| Biomolecule | RNAs |
| Subject | Human |
| Degree of Validity | Potential prognostic and diagnostic markers for HCC associated with HCV and validated on independent dataset |
| Experimental Condition | HCC with Cirrhosis v/s HCC without Cirrhosis |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Downregulated |
| Level of significance | p < 0.05 |
| Source | Tissue |
| PMID | 18959789 |
| Type of Biomarker | Diagnostic and prognostic |
| Pathway | Immune response |
| Cohort | Paired tumor and non-tumor samples of 17 patients; validation daatset:Ten samples of human DNA and RNA were extracted from PBL and normal liver tissue |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | HCV-associated HCC |
| Year of Publication | 2008 |
| Clinical trial | YES |
| NCT No# (Clinical trial) | NCT00006198,NCT02148562,NCT02644603,NCT01964001,NCT00427973,NCT00629486,NCT00629668 |